Research

Gastrointestinal Cancer Clinical Trials

The following clinical trials related to gastrointestinal cancers are available through the WPAHS. Please click on the link for more detailed information on the trial. Below each trial is the contact information at the WPAHS.

Colon and Rectal Trials

Study Title

P-5, Statin Polyp Prevention Trial in Patients with Resected Colon Cancer

Principal Investigator: Thomas Julian, M.D.

Please also contact study coordinator for more information:

Stephanie Kenney, CRC (Phone 412.359.4856)

Internal Reference: (RC-5026/NSABP Julian)

Study Title

FC-6 BMS CA 225-341 -- A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant Mfolfox7 Plus Cetuximab for Unresectable Wild-Type K-RAS Colorectal Cancer with Metastases Confined to the Liver

Principal Investigator: Thomas Julian, M.D.

Please also contact study coordinator for more information:

Gloria Flannery, RN (Phone 412.359.8379)

Internal Reference: (RC-4999/NSABP FRP Julian)

Study Title

A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for recurrence to Determine Prospectively the Prognostic Value of Molecular Marker

Principal Investigator: David Medich, M.D.

Please also contact study coordinator for more information:

Irina Barskaya, MD, CRA (412.35.6165)

Internal Reference: (RC- 4199/E5202 Medich)

Study Title

A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum

Principal Investigator: John Lister, M.D.

Please also contact study coordinator for more information:

Rich Wonder, RN, CCRC (Phone 412.578.4492)

Internal Reference: (IRB 05-11-082-RS/CALGB C 80405 Lister)

Study Title

A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer

Principal Investigator: James McCormick, M.D.

Please also contact study coordinator for more information:

Laura Gibson, RN, CCRC (Phone 412.578.4439)

Internal Reference: (IRB 09-021/ACOSOG Z6051 McCormick)

Study Title

NSABP NCI CIRB C-11: A Phase III Study Evaluating the Role of Perioperative Chemotherapy and Bevacizumab in Patients with Potentially Resectable Hepatic Colorectal Metastases

Principal Investigator: Thomas Julian, M.D.

Please also contact study coordinator for more information:

Gloria Flannery, RN (Phone 412.359.8379)

Internal Reference: (RC-5097/NSABP C-11 Julian)

Pancreatic Cancer Trials

Study Title

A Randomized Cross-over Phase 2 Study for Previously Untreated Patients with Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma

Principal Investigator: Jane Raymond, M.D.

Please also contact study coordinator for more information:

Gloria Flannery, RN (Phone 412.359.8379)

Internal Reference: (RC-5086/Raymond)

Study Title

RTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

Principal Investigator: Jane Raymond, M.D.

Please also contact study coordinator for more information:

Gloria Flannery, RN (Phone 412.359.8379)

Internal Reference: (RC-5147/CTSU/RTOG 0848)